Beyond Primary HER2 Expression: Trastuzumab Deruxtecan’s Efficacy in Brain Metastasis is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health (NIH)
Grant: R01CA238727
National Institutes of Health (NIH)
Grant: U01CA253553
National Institutes of Health (NIH)
Grant: U01CA268813
NIH HHS
Grant: 3U01CA253553-24S1
NIH HHS
Grant: 5R01CA238727-05A1
National Institutes of Health
Grant: 1U01CA268813-01
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
National Institutes of Health
Grant: 5U01CA253553-04
Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis
National Institutes of Health
Grant: 3R01CA238727-03S1
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
T.T. and W.F. Chao Foundation
Houston Methodist Cornerstone Award
John S. Dunn Research Foundation
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals